Martinuzzo Marta E, Cerrato Graciela S, Iglesias Varela Maria L, Adamczuk Yolanda P, Pombo Gonzalo, Forastiero Ricardo R
Laboratorio de Hemostasia y Trombosis, Servicio de Hematología, Fundación Favaloro, Hospital Universitario, Universidad Favaloro, Buenos Aires.
Medicina (B Aires). 2012;72(1):19-22.
Heparin induced thrombocytopenia (HIT) is an immune-mediated disorder due to antibodies anti platelet factor 4-heparin (HPIA). Thrombocytopenia is often moderate but certain patients can develop morbid thrombotic complications. HPIA detection by ELISA has high sensitivity but low specificity, and low titers (without clinical significance) are frequent. A pretest clinical score (4T's) was developed in order to recognize patients that are at high risk of HIT. The aim of this study was to correlate HPIA levels and the 4T's score of consecutive patients derived to our center. We evaluated 84 patients (35 of them developed thrombosis); the clinical questionnaire was sent along with the sample and was analyzed by an investigator who did not know the patients' characteristics, and 4T's scores were calculated before performing the laboratory tests. HPIA were measured by ELISA (Asserachrom HPIA) that detects IgG, IgM and IgA isotypes, (the only reagent available in our country). 4T's score correlated with HPIA levels (rho spearman 0.472, p < 0.001). Patients with 4T's = 6 had higher absorbance percentages than those with = 5 (67 vs. 39%, p < 0.001), and patients with thrombosis also presented higher titers (59 vs. 39%, p = 0.017) than those who did not develop this complication. In conclusion, high titers of HPIA measured by EIA which detects the 3 isotypes, clearly correlate with 4T's score = 6 and are more frequent in patients who develop thrombosis, just as reported when an IgG specific ELISA is used.
肝素诱导的血小板减少症(HIT)是一种由抗血小板因子4-肝素抗体(HPIA)介导的免疫性疾病。血小板减少症通常为中度,但某些患者可能会发生严重的血栓并发症。通过酶联免疫吸附测定(ELISA)检测HPIA具有高敏感性但低特异性,并且低滴度(无临床意义)很常见。为了识别HIT高危患者,制定了一个预测试临床评分(4T's)。本研究的目的是将连续转诊至我们中心的患者的HPIA水平与4T's评分相关联。我们评估了84例患者(其中35例发生了血栓形成);临床问卷与样本一起发送,并由一名不了解患者特征的研究人员进行分析,并且在进行实验室检测之前计算4T's评分。通过ELISA(Asserachrom HPIA)检测HPIA,该方法可检测IgG、IgM和IgA同种型(我国唯一可用的试剂)。4T's评分与HPIA水平相关(Spearman相关系数rho为0.472,p < 0.001)。4T's = 6的患者比4T's = 5的患者具有更高的吸光度百分比(67%对39%,p < 0.001),并且发生血栓形成的患者也比未发生该并发症的患者具有更高的滴度(59%对39%,p = 0.017)。总之,通过检测3种同种型的酶免疫测定法测得的高滴度HPIA与4T's评分 = 6明显相关,并且在发生血栓形成的患者中更常见,正如使用IgG特异性ELISA时所报道的那样。